Skip to content

Management of Uterine Leiomyomata and Adenomyosis

Management of Uterine Leiomyomata and Adenomyosis : Role of Hysteroscopy in Diagnosis and Norethisterone in the Treatment

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05153928
Enrollment
100
Registered
2021-12-10
Start date
2021-04-10
Completion date
2021-12-25
Last updated
2021-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormal Uterine Bleeding

Brief summary

1. to determine the role of hysteroscopy and guided biopsy to differentiate between submucosal fibroids and adenomyosis confirmed by histopathological examination 2. to evaluate the efficacy of norethisterone in the treatment of symptomatic adenomyosis and leiomyoma

Detailed description

The aim of the present study is: 1. to determine the role of hysteroscopy and guided biopsy to differentiate between submucosal fibroids and adenomyosis confirmed by histopathological examination 2. to evaluate the efficacy of norethisterone in the treatment of symptomatic adenomyosis and leiomyoma

Interventions

Norethisterone acetate for 5 months

Sponsors

Assiut University
CollaboratorOTHER
Ahmed Ali Mahmoud
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
OTHER

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

\- (1) age≥30 years; (4) dysmenorrhea, adenomyosis-associated chronic pain, and/or menorrhagia. (3) regular menstrual cycles before administration of norethisterone; (4) no other treatment for adenomyosis/leiomyomatosis at least for 3 months biopsies and histopathology for operated patients;

Exclusion criteria

* (1) pregnant and/or breast-feeding women (2) patients with a ovarian neoplasm, benign ovarian cyst including endometrioma, pelvic inflammatory disease or other endocrine diseases.

Design outcomes

Primary

MeasureTime frameDescription
is to evaluate sensitivity and specificity of hysteroscopy in differentiating between uterine adenomyosis and leiomyomatosis6 monthsSymptomatic improvement

Countries

Egypt

Contacts

Primary Contactahmed Al Dr, Msc
rcogahmedali@gmail.com00201003734246
Backup ContactAhmed Ali
Drarmy1984@gmail.com00201003734246

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026